Acceptable performance for the accuracy-based creatinine testing program
| Year-round | Specimen name | Acceptable performance | ||
|---|---|---|---|---|
| Creatinine | eGFR | |||
| CKD-EPI | MDRD 4 variable (IDMS-traceable) | |||
| 2020-1st | CAC-20-01 | 1,458 (88.6) | 93 (94.9) | 448 (99.8) |
| CAC-20-02 | 1,562 (95.0) | 93 (94.9) | 445 (99.1) | |
| CAC-20-03 | 1,559 (94.8) | 90 (91.8) | 441 (98.2) | |
| 2020-2nd | CAC-20-04 | 1,536 (92.3) | 97 (96.0) | 461 (98.5) |
| CAC-20-05 | 1,546 (92.9) | 98 (97.0) | 461 (98.5) | |
| CAC-20-06 | 1,561 (93.8) | 95 (94.1) | 454 (97.0) | |
| 2021-1st | CAC-21-01 | 1,123 (69.2) | 99 (97.1) | 463 (98.3) |
| CAC-21-02 | 1,425 (87.8) | 99 (97.1) | 464 (98.5) | |
| CAC-21-03 | 1,491 (91.9) | 100 (98.0) | 459 (97.5) | |
| 2021-2nd | CAC-21-04 | 1,364 (82.9) | 120 (99.2) | 452 (98.5) |
| CAC-21-05 | 1,410 (85.7) | 120 (99.2) | 455 (99.1) | |
| CAC-21-06 | 1,532 (93.1) | 118 (97.5) | 445 (96.9) | |
Values are presented as number (%).
Abbreviations: eGFR, estimated glomerular filtration rate; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; MDRD, Modification of Diet in Renal Disease; IDMS, isotope-dilution mass spectrometry.